Kura Oncology, Inc. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Kura Oncology filed an 8-K on 2026-09-09 disclosing Item 8.01 (Other Events), but the actual text content of the filing is not provided in this submission extract. No counterparties, dollar amounts, dates, or business changes can be identified from the available document metadata alone.
Why this rating
Filing appears procedural with no disclosed material event details; unable to assess substance without actual 8-K text content.
Extracted items
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.